Etanercept (Enbrel®) therapy for chronic inflammatory demyelinating polyneuropathy
Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and/or variants who were refractory or intolerant of standard therapies were treated with etanercept, 25 mg twice per week. Ten patients underwent treatment, and manual muscle strength, sensory thresholds and functional abilities...
Saved in:
| Published in | Journal of the neurological sciences Vol. 210; no. 1; pp. 19 - 21 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Shannon
Elsevier B.V
15.06.2003
Elsevier Science |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and/or variants who were refractory or intolerant of standard therapies were treated with etanercept, 25 mg twice per week. Ten patients underwent treatment, and manual muscle strength, sensory thresholds and functional abilities were tested prior to and 4–6 months after initiating therapy. Three patients had significant improvement and three others had possible improvement. Based on these preliminary observations, treatment with etanercept may be considered in patients with CIDP, who cannot undergo standard therapies, although its efficacy in CIDP needs to be examined in a double-blinded, controlled clinical trial. |
|---|---|
| AbstractList | Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and/or variants who were refractory or intolerant of standard therapies were treated with etanercept, 25 mg twice per week. Ten patients underwent treatment, and manual muscle strength, sensory thresholds and functional abilities were tested prior to and 4–6 months after initiating therapy. Three patients had significant improvement and three others had possible improvement. Based on these preliminary observations, treatment with etanercept may be considered in patients with CIDP, who cannot undergo standard therapies, although its efficacy in CIDP needs to be examined in a double-blinded, controlled clinical trial. |
| Author | Sherman, William H Latov, Norman Hays, Arthur P Sander, Howard W Chin, Russell L |
| Author_xml | – sequence: 1 givenname: Russell L surname: Chin fullname: Chin, Russell L email: ruc9002@med.cornell.edu organization: Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USA – sequence: 2 givenname: William H surname: Sherman fullname: Sherman, William H organization: Department of Medicine, Columbia University, New York, NY, USA – sequence: 3 givenname: Howard W surname: Sander fullname: Sander, Howard W organization: Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USA – sequence: 4 givenname: Arthur P surname: Hays fullname: Hays, Arthur P organization: Department of Pathology, Columbia University, New York, NY, USA – sequence: 5 givenname: Norman surname: Latov fullname: Latov, Norman organization: Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14746068$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12736082$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0M1u1DAQwHELFdFt4RFAuYDaQ8AfceycEKq2gFSJQ0HiZjmTMWuU2MH2IuWleAierGl3RY-cfPnN2P6fkZMQAxLyktG3jLL23S2lnNeS0e8XVFxSShmt9ROyYVrpWmotTsjmHzklZzn_XFGrdfeMnDKuREs135DbbbEBE-Bcqott6BOOf_9cVmWHyc5L5WKqYJdi8FD54EY7TbbEtFQDTguOPtjiw49qjuMScJ_ibMtueU6eOjtmfHE8z8m36-3Xq0_1zZePn68-3NTQSFVqFFLaBloL2PAOKGecNR1o6ZBZyjsletVbxWCQXDoxOOq47RUX0HWix06ckzeHvXOKv_aYi5l8BhzH9Udxn40SvBWSsRXKA4QUc07ozJz8ZNNiGDX3Nc1DTXOfylBhHmoavc69Ol6w7yccHqeO-Vbw-ghsBju6ZAP4_Oga1bRr89W9Pzhcc_z2mEwGjwFw8AmhmCH6_zzlDo5FlPI |
| CODEN | JNSCAG |
| CitedBy_id | crossref_primary_10_1056_NEJMra041347 crossref_primary_10_1016_S0035_3787_04_70892_9 crossref_primary_10_1111_jns_12455 crossref_primary_10_1007_s11910_015_0563_z crossref_primary_10_1016_j_clim_2007_08_012 crossref_primary_10_2217_nmt_2017_0017 crossref_primary_10_1002_14651858_CD003280_pub5 crossref_primary_10_1002_mus_20924 crossref_primary_10_1111_j_1600_0404_2005_00448_x crossref_primary_10_1517_14656560903036095 crossref_primary_10_2165_00023210_200519120_00005 crossref_primary_10_1016_S0035_3787_07_92166_9 crossref_primary_10_1016_j_sder_2010_02_002 crossref_primary_10_1097_WCO_0b013e3283394203 crossref_primary_10_2492_inflammregen_26_148 crossref_primary_10_1097_01_cnd_0000205575_26451_e4 crossref_primary_10_1517_14712598_8_5_643 crossref_primary_10_1016_S0035_3787_07_78408_4 crossref_primary_10_1016_S0035_3787_06_75048_2 crossref_primary_10_1097_MAJ_0b013e31822b7bb8 crossref_primary_10_1111_j_1759_1961_2010_00015_x crossref_primary_10_2332_allergolint_54_191 crossref_primary_10_1186_s41983_019_0133_4 crossref_primary_10_1007_s11940_010_0058_9 crossref_primary_10_1016_j_ncl_2013_01_006 crossref_primary_10_1186_s12974_017_1001_8 crossref_primary_10_1111_j_1085_9489_2005_0010203_x crossref_primary_10_1002_mus_21051 crossref_primary_10_1097_00019052_200410000_00011 crossref_primary_10_1007_s11940_006_0001_2 crossref_primary_10_1007_s00415_005_0805_0 crossref_primary_10_1016_j_jns_2013_01_003 crossref_primary_10_1016_j_ncl_2006_11_003 crossref_primary_10_1073_pnas_2114406119 crossref_primary_10_1038_ncpneuro0452 crossref_primary_10_1136_jnnp_2008_158303 crossref_primary_10_1016_j_berh_2006_06_002 crossref_primary_10_1007_s00415_005_1103_6 crossref_primary_10_1007_s11910_007_0023_5 crossref_primary_10_2217_imt_15_107 crossref_primary_10_1517_14656566_6_4_569 crossref_primary_10_1016_j_mayocp_2018_03_026 crossref_primary_10_1212_01_WNL_0000158681_29117_8B crossref_primary_10_1016_j_rdc_2004_02_003 crossref_primary_10_1111_j_1479_8077_2007_00316_x crossref_primary_10_2119_molmed_2009_00041 crossref_primary_10_1016_j_jaad_2005_03_062 crossref_primary_10_1586_eci_09_80 crossref_primary_10_1007_s11910_009_0011_z crossref_primary_10_1111_ene_14959 crossref_primary_10_1111_j_1365_2265_2005_02376_x crossref_primary_10_1136_jnnp_2006_089433 crossref_primary_10_1177_2058739220942340 crossref_primary_10_1002_mus_21748 crossref_primary_10_1002_mus_21277 crossref_primary_10_1177_1756285612457215 crossref_primary_10_1586_14737175_6_3_365 crossref_primary_10_1016_S1474_4422_10_70041_7 crossref_primary_10_2165_00003495_200969080_00004 crossref_primary_10_1016_j_revmed_2009_08_006 crossref_primary_10_1111_bcpt_12261 |
| Cites_doi | 10.1016/S0304-3959(97)00148-6 10.1016/S0304-3940(01)01877-8 10.1016/S0022-510X(99)00009-X 10.1001/archneur.1989.00520440064022 10.1212/WNL.56.4.445 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A 10.1046/j.1529-8027.2000.00012.x 10.1046/j.1529-8027.2001.01010.x 10.1016/0960-8966(96)00356-2 10.1056/NEJM198602203140801 10.1056/NEJM199707173370301 10.1002/(SICI)1097-4598(200002)23:2<295::AID-MUS26>3.0.CO;2-C 10.1212/WNL.48.2.321 10.1136/jnnp.45.10.866 10.1212/WNL.56.5.666 10.1046/j.1365-2125.2001.00321.x 10.1002/ana.1088 |
| ContentType | Journal Article |
| Copyright | 2003 Elsevier Science B.V. 2003 INIST-CNRS |
| Copyright_xml | – notice: 2003 Elsevier Science B.V. – notice: 2003 INIST-CNRS |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/S0022-510X(03)00010-8 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1878-5883 |
| EndPage | 21 |
| ExternalDocumentID | 10_1016_S0022_510X_03_00010_8 12736082 14746068 S0022510X03000108 |
| Genre | Journal Article Comparative Study |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXLA AAXUO ABBQC ABCQJ ABFNM ABFRF ABGSF ABIVO ABJNI ABLJU ABLVK ABMAC ABMZM ABTEW ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGWIK AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK AKRLJ ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HVGLF HZ~ IHE J1W KOM L7B LCYCR LX8 M29 M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SSH SSN SSU SSZ T5K WUQ X7M Z5R ZA5 ZGI ZXP ~G- AAUGY ABPIF ABPTK IQODW AKRWK CGR CUY CVF ECM EIF NPM AAXKI AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c457t-e355a4c6ace429c0212149c85fe1a02973b7ba71cd525f3df0f2ab723c993be93 |
| IEDL.DBID | .~1 |
| ISSN | 0022-510X |
| IngestDate | Fri Aug 16 08:53:18 EDT 2024 Thu Sep 12 18:54:54 EDT 2024 Thu May 23 23:51:31 EDT 2024 Sun Oct 22 16:02:13 EDT 2023 Fri Feb 23 02:31:56 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Therapy Tumor necrosis factor (TNF) Polyneuropathy Etanercept (Enbrel®) Demyelination Chronic inflammatory demyelinating polyneuropathy (CIDP) Human Nervous system diseases Cytokine Inflammatory disease Case study Chemotherapy Chronic Treatment Etanercept Peripheral nerve disease Antagonist Tumor necrosis factor α |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c457t-e355a4c6ace429c0212149c85fe1a02973b7ba71cd525f3df0f2ab723c993be93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 12736082 |
| PQID | 73263511 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | proquest_miscellaneous_73263511 crossref_primary_10_1016_S0022_510X_03_00010_8 pubmed_primary_12736082 pascalfrancis_primary_14746068 elsevier_sciencedirect_doi_10_1016_S0022_510X_03_00010_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2003-06-15 |
| PublicationDateYYYYMMDD | 2003-06-15 |
| PublicationDate_xml | – month: 06 year: 2003 text: 2003-06-15 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | Shannon |
| PublicationPlace_xml | – name: Shannon – name: Netherlands |
| PublicationTitle | Journal of the neurological sciences |
| PublicationTitleAlternate | J Neurol Sci |
| PublicationYear | 2003 |
| Publisher | Elsevier B.V Elsevier Science |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier Science |
| References | Mendell, Barohn, Kissel, Sanders, King, Campbell (BIB5) 2001; 56 Gorson, Allam, Ropper (BIB9) 1997; 48 Latov, Sherman (BIB12) 2000; 48 Pentland, Adams, Mawdsley (BIB6) 1982; 45 Briani, Brannagan, Trojaborg, Latov (BIB2) 1996; 6 Seymour, Worsley, Smith, Thomas (BIB11) 2001; 51 Moreland, Baumgartner, Schiff (BIB10) 1997; 337 Dyck, Daube, O'Brien, Pineda, Low, Windebank, Swanson (BIB3) 1986; 314 Hughes, Bensa, Willison, Swan (BIB4) 2001; 50 Mathey, Pollard, Armati (BIB13) 1999; 163 Misawa, Kuwabara, Mori, Kawaguchi, Yoshiyama, Hattori (BIB15) 2001; 56 Sommer, Schafers, Marziniak, Toyka (BIB18) 2001; 6 Barohn, Kissel, Warmolts, Mendell (BIB1) 1989; 46 Sorkin, Doom (BIB14) 2000; 5 Wagner, Janjigian, Myers (BIB16) 1998; 74 Harada, Ohkoshi, Fujita, Tamaoka, Shoji (BIB8) 2000; 23 Saperstein, Katz, Amato, Barohn (BIB7) 2001; 24 Weishaupt, Bruck, Hartung, Toyka, Gold (BIB17) 2001; 306 Harada (10.1016/S0022-510X(03)00010-8_BIB8) 2000; 23 Weishaupt (10.1016/S0022-510X(03)00010-8_BIB17) 2001; 306 Sommer (10.1016/S0022-510X(03)00010-8_BIB18) 2001; 6 Briani (10.1016/S0022-510X(03)00010-8_BIB2) 1996; 6 Sorkin (10.1016/S0022-510X(03)00010-8_BIB14) 2000; 5 Dyck (10.1016/S0022-510X(03)00010-8_BIB3) 1986; 314 Mendell (10.1016/S0022-510X(03)00010-8_BIB5) 2001; 56 Gorson (10.1016/S0022-510X(03)00010-8_BIB9) 1997; 48 Hughes (10.1016/S0022-510X(03)00010-8_BIB4) 2001; 50 Pentland (10.1016/S0022-510X(03)00010-8_BIB6) 1982; 45 Latov (10.1016/S0022-510X(03)00010-8_BIB12) 2000; 48 Wagner (10.1016/S0022-510X(03)00010-8_BIB16) 1998; 74 Misawa (10.1016/S0022-510X(03)00010-8_BIB15) 2001; 56 Barohn (10.1016/S0022-510X(03)00010-8_BIB1) 1989; 46 Moreland (10.1016/S0022-510X(03)00010-8_BIB10) 1997; 337 Saperstein (10.1016/S0022-510X(03)00010-8_BIB7) 2001; 24 Seymour (10.1016/S0022-510X(03)00010-8_BIB11) 2001; 51 Mathey (10.1016/S0022-510X(03)00010-8_BIB13) 1999; 163 |
| References_xml | – volume: 6 start-page: 311 year: 1996 end-page: 325 ident: BIB2 article-title: Chronic inflammatory demyelinating polyneuropathy publication-title: Neuromuscul. Disord. contributor: fullname: Latov – volume: 5 start-page: 96 year: 2000 end-page: 100 ident: BIB14 article-title: Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat publication-title: J. Peripher. Nerv. Syst. contributor: fullname: Doom – volume: 51 start-page: 201 year: 2001 end-page: 208 ident: BIB11 article-title: Anti-TNF agents for rheumatoid arthritis publication-title: Br. J. Clin. Pharmacol. contributor: fullname: Thomas – volume: 23 start-page: 295 year: 2000 end-page: 296 ident: BIB8 article-title: Clinical improvement following interferon-alpha alone as an initial treatment in CIDP publication-title: Muscle Nerve contributor: fullname: Shoji – volume: 306 start-page: 77 year: 2001 end-page: 80 ident: BIB17 article-title: Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α publication-title: Neurosci. Lett. contributor: fullname: Gold – volume: 163 start-page: 47 year: 1999 end-page: 52 ident: BIB13 article-title: TNFα, IFNγ, and IL-2 mRNA expression in CIDP sural nerve biopsies publication-title: J. Neurol. Sci. contributor: fullname: Armati – volume: 50 start-page: 195 year: 2001 end-page: 201 ident: BIB4 article-title: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy publication-title: Ann. Neurol. contributor: fullname: Swan – volume: 24 start-page: 311 year: 2001 end-page: 324 ident: BIB7 article-title: Clinical spectrum of chronic acquired demyelinating polyneuropathies publication-title: Muscle Nerve contributor: fullname: Barohn – volume: 314 start-page: 461 year: 1986 end-page: 465 ident: BIB3 article-title: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy publication-title: N. Engl. J. Med. contributor: fullname: Swanson – volume: 48 start-page: 321 year: 1997 end-page: 328 ident: BIB9 article-title: Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy publication-title: Neurology contributor: fullname: Ropper – volume: 74 start-page: 35 year: 1998 end-page: 42 ident: BIB16 article-title: Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression publication-title: Pain contributor: fullname: Myers – volume: 56 start-page: 445 year: 2001 end-page: 449 ident: BIB5 article-title: Intravenous immunoglobulin in untreated patients with chronic inflammatory demyelinating polyneuropathy publication-title: Neurology contributor: fullname: Campbell – volume: 337 start-page: 141 year: 1997 end-page: 147 ident: BIB10 article-title: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein publication-title: N. Engl. J. Med. contributor: fullname: Schiff – volume: 46 start-page: 878 year: 1989 end-page: 884 ident: BIB1 article-title: Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria publication-title: Arch. Neurol. contributor: fullname: Mendell – volume: 48 start-page: 473 year: 2000 ident: BIB12 article-title: Improvement with etanercept (Enbrel) in chronic inflammatory demyelinating polyneuropathy publication-title: Ann. Neurol. contributor: fullname: Sherman – volume: 56 start-page: 666 year: 2001 end-page: 669 ident: BIB15 article-title: Serum levels of tumor necrosis factor-α in chronic inflammatory demyelinating polyneuropathy publication-title: Neurology contributor: fullname: Hattori – volume: 45 start-page: 866 year: 1982 end-page: 869 ident: BIB6 article-title: Chronic idiopathic polyneuropathy treated with azathioprine publication-title: J. Neurol. Neurosurg. Psychiatry contributor: fullname: Mawdsley – volume: 6 start-page: 67 year: 2001 end-page: 72 ident: BIB18 article-title: Etanercept reduces hyperalgesia in experimental painful neuropathy publication-title: J. Peripher. Nerv. Syst. contributor: fullname: Toyka – volume: 74 start-page: 35 year: 1998 ident: 10.1016/S0022-510X(03)00010-8_BIB16 article-title: Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression publication-title: Pain doi: 10.1016/S0304-3959(97)00148-6 contributor: fullname: Wagner – volume: 306 start-page: 77 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB17 article-title: Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-α publication-title: Neurosci. Lett. doi: 10.1016/S0304-3940(01)01877-8 contributor: fullname: Weishaupt – volume: 163 start-page: 47 year: 1999 ident: 10.1016/S0022-510X(03)00010-8_BIB13 article-title: TNFα, IFNγ, and IL-2 mRNA expression in CIDP sural nerve biopsies publication-title: J. Neurol. Sci. doi: 10.1016/S0022-510X(99)00009-X contributor: fullname: Mathey – volume: 46 start-page: 878 year: 1989 ident: 10.1016/S0022-510X(03)00010-8_BIB1 article-title: Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria publication-title: Arch. Neurol. doi: 10.1001/archneur.1989.00520440064022 contributor: fullname: Barohn – volume: 56 start-page: 445 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB5 article-title: Intravenous immunoglobulin in untreated patients with chronic inflammatory demyelinating polyneuropathy publication-title: Neurology doi: 10.1212/WNL.56.4.445 contributor: fullname: Mendell – volume: 24 start-page: 311 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB7 article-title: Clinical spectrum of chronic acquired demyelinating polyneuropathies publication-title: Muscle Nerve doi: 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A contributor: fullname: Saperstein – volume: 48 start-page: 473 year: 2000 ident: 10.1016/S0022-510X(03)00010-8_BIB12 article-title: Improvement with etanercept (Enbrel) in chronic inflammatory demyelinating polyneuropathy publication-title: Ann. Neurol. contributor: fullname: Latov – volume: 5 start-page: 96 year: 2000 ident: 10.1016/S0022-510X(03)00010-8_BIB14 article-title: Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat publication-title: J. Peripher. Nerv. Syst. doi: 10.1046/j.1529-8027.2000.00012.x contributor: fullname: Sorkin – volume: 6 start-page: 67 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB18 article-title: Etanercept reduces hyperalgesia in experimental painful neuropathy publication-title: J. Peripher. Nerv. Syst. doi: 10.1046/j.1529-8027.2001.01010.x contributor: fullname: Sommer – volume: 6 start-page: 311 year: 1996 ident: 10.1016/S0022-510X(03)00010-8_BIB2 article-title: Chronic inflammatory demyelinating polyneuropathy publication-title: Neuromuscul. Disord. doi: 10.1016/0960-8966(96)00356-2 contributor: fullname: Briani – volume: 314 start-page: 461 year: 1986 ident: 10.1016/S0022-510X(03)00010-8_BIB3 article-title: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198602203140801 contributor: fullname: Dyck – volume: 337 start-page: 141 year: 1997 ident: 10.1016/S0022-510X(03)00010-8_BIB10 article-title: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199707173370301 contributor: fullname: Moreland – volume: 23 start-page: 295 year: 2000 ident: 10.1016/S0022-510X(03)00010-8_BIB8 article-title: Clinical improvement following interferon-alpha alone as an initial treatment in CIDP publication-title: Muscle Nerve doi: 10.1002/(SICI)1097-4598(200002)23:2<295::AID-MUS26>3.0.CO;2-C contributor: fullname: Harada – volume: 48 start-page: 321 year: 1997 ident: 10.1016/S0022-510X(03)00010-8_BIB9 article-title: Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy publication-title: Neurology doi: 10.1212/WNL.48.2.321 contributor: fullname: Gorson – volume: 45 start-page: 866 year: 1982 ident: 10.1016/S0022-510X(03)00010-8_BIB6 article-title: Chronic idiopathic polyneuropathy treated with azathioprine publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.45.10.866 contributor: fullname: Pentland – volume: 56 start-page: 666 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB15 article-title: Serum levels of tumor necrosis factor-α in chronic inflammatory demyelinating polyneuropathy publication-title: Neurology doi: 10.1212/WNL.56.5.666 contributor: fullname: Misawa – volume: 51 start-page: 201 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB11 article-title: Anti-TNF agents for rheumatoid arthritis publication-title: Br. J. Clin. Pharmacol. doi: 10.1046/j.1365-2125.2001.00321.x contributor: fullname: Seymour – volume: 50 start-page: 195 year: 2001 ident: 10.1016/S0022-510X(03)00010-8_BIB4 article-title: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy publication-title: Ann. Neurol. doi: 10.1002/ana.1088 contributor: fullname: Hughes |
| SSID | ssj0006889 |
| Score | 2.0591514 |
| Snippet | Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and/or variants who were refractory or intolerant of standard therapies were treated... |
| SourceID | proquest crossref pubmed pascalfrancis elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 19 |
| SubjectTerms | Adult Aged Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Biological and medical sciences Chronic inflammatory demyelinating polyneuropathy (CIDP) Combined Modality Therapy Demyelination Drug Administration Schedule Etanercept Etanercept (Enbrel®) Female Humans Immunoglobulin G - therapeutic use Immunomodulators Male Medical sciences Middle Aged Movement - physiology Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Muscle, Skeletal - drug effects Muscle, Skeletal - physiopathology Neural Conduction Neurology Pharmacology. Drug treatments Polyneuropathy Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy Receptors, Tumor Necrosis Factor - therapeutic use Therapy Treatment Outcome Tumor necrosis factor (TNF) |
| Title | Etanercept (Enbrel®) therapy for chronic inflammatory demyelinating polyneuropathy |
| URI | https://dx.doi.org/10.1016/S0022-510X(03)00010-8 https://www.ncbi.nlm.nih.gov/pubmed/12736082 https://search.proquest.com/docview/73263511 |
| Volume | 210 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LawIxEA5ioRRK6bv2YXPoQQ_R3U32dRRRbIteWsFbyO5mQbDrUvXgpT-pP6K_rJNkl8WDFHoN2WyYmcx8w7wQehIJ8DkUDgivGxKWSEpClggiQzWuO_EDqcujxxNvNGUvM3dWQ_2yFkalVRa63-h0ra2LlW5BzW4-n6saX5BF25qBmCrPRhX8MjBGINOdryrNwwuCsOwYrnZXVTzmBL3YsmhbH0KCffbpOBcroFpqxl3sx6PaLg1P0UkBKHHP3PkM1WR2jg7HRcj8Ar0NAP6Z7BXcGmTgAS9-vtvY1F1tMWBWHJsGuRiEDeTjQ8fdsaozUbXqQuVF43y52OrWl2qC8fYSTYeD9_6IFJMUSMxcf00koArBYk_EEuxPrNq6g2cUB24qbaHHV0V-JHw7TlzHTWmSWqkjIt-hMcCXSIb0CtWzZSZvEPZCmYpAMHCTInj8tvBYSqkVSdXRkDphA3VK-vHcNMzgVSYZEJwrgnOL6rC3xYMGCkoq8x3Oc1Dqf33a3OFK9UPmM_DMYMNjySYOz0bFQoDky82K-1R14bHtBro23Ku-BUDnATC6_f-97tCRY6Y0Etu9R_X150Y-AHZZR00tnE100Ht-HU1-ATU36Q0 |
| link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB58gAoivq2Pdg8e2kM0yW6SzVGkUrXtRQu9LZtkAwVti20PvfiT_BH-Mmd3E4KHInhd9sXM7Ow3zAvgWmbI51j6KLxB7LBMUSdmmXRUrNt1ZxFXJj261w87A_Y0DIZrcF_mwuiwykL3W51utHUxcltQ83Y6GukcX5RFzx2imGrLhq_Dpobzun_DzWcV5xFyHpclw_X0Ko3HbmEGmy5tmV0cvuqD2p3KGZItt_0uVgNS8zE97MNegSjJnb30Aayp8SFs9Qqf-RG8tBH_2fAV0myP0QR--_5qEZt4tSQIWklqK-QSlDYUkHfjeCc60UQnq0sdGE2mk7elqX2pWxgvj2Hw0H697zhFKwUnZUE0dxTCCsnSUKYKP6BU13VH0yjlQa48afpXJVEiIy_NAj_IaZa7uS-TyKcp4pdExfQENsaTsToDEsYql1wytJMSfP2eDFlOqZsoXdKQ-nENbkr6iamtmCGqUDIkuNAEFy41fm9X8BrwksriF-sFavW_ltZ_caU6kEUMTTOc0CjZJPDdaGcIknyymImI6jI8nleDU8u9ai0iuhCR0fn_79WA7c5rryu6j_3nC9jxbctGxwsuYWP-sVBXCGTmSd0I6g-jw-qf |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Etanercept+%28Enbrel%C2%AE%29+therapy+for+chronic+inflammatory+demyelinating+polyneuropathy&rft.jtitle=Journal+of+the+neurological+sciences&rft.au=Chin%2C+Russell+L&rft.au=Sherman%2C+William+H&rft.au=Sander%2C+Howard+W&rft.au=Hays%2C+Arthur+P&rft.date=2003-06-15&rft.issn=0022-510X&rft.volume=210&rft.issue=1-2&rft.spage=19&rft.epage=21&rft_id=info:doi/10.1016%2FS0022-510X%2803%2900010-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0022_510X_03_00010_8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-510X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-510X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-510X&client=summon |